Literature DB >> 23496116

Disseminated histoplasmosis and aids: relapse and late mortality in endemic area in North-Eastern Brazil.

Lisandra Serra Dasmasceno1, Alberto Ramos Novaes, Carlos Henrique Morais Alencar, Daniel Teixeira Lima, José Júlio Costa Sidrim, Maria Vânia Freitas Gonçalves, Jacó Ricarte Lima de Mesquita, Terezinha do Menino Jesus Silva Leitão.   

Abstract

The State of Ceará in north-eastern Brazil has one of the highest rates in the world of relapse and death due to disseminated histoplasmosis (DH) in acquired immunodeficiency syndrome (AIDS) patients. The objective of this study is to characterise the relapse and mortality of DH in AIDS cases residents in Ceará. We performed a retrospective analysis of the medical records of AIDS patients who had a first episode of DH from 2002 to 2008. We analysed the outcomes until December 31, 2010. A total of 145 patients participated in the study. The mean clinical follow-up duration was 3.38 years (SD = 2.2; 95% CI = 3.01-3.75). The majority of the subjects were male with a mean age of 35 years (SD = 2.2; 95% CI = 3.01-3.75) and were born in the capital of Ceará. DH was the first manifestation of AIDS in 59% of the patients. The relapse rate was 23.3%, with a disseminated presentation in 90% of these patients. The overall mortality during the study period was 30.2%. The majority of patients who relapsed or died had irregular treatment with antifungals or highly active antiretroviral therapy and did not have active clinical follow-up. High rates of recurrence and mortality were found in AIDS-associated DH in this area of the country.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  AIDS; disseminated histoplasmosis; mortality; mycoses

Mesh:

Year:  2013        PMID: 23496116     DOI: 10.1111/myc.12067

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Endemic mycoses in immunocompromised hosts.

Authors:  Trent R Malcolm; Peter V Chin-Hong
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

Review 2.  The use of genetic markers in the molecular epidemiology of histoplasmosis: a systematic review.

Authors:  L S Damasceno; T M J S Leitão; M L Taylor; M M Muniz; R M Zancopé-Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-20       Impact factor: 3.267

3.  Treating progressive disseminated histoplasmosis in people living with HIV.

Authors:  Marylou Murray; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

Review 4.  Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?

Authors:  Laura Elena Carreto-Binaghi; Lisandra Serra Damasceno; Nayla de Souza Pitangui; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Rosely Maria Zancopé-Oliveira; Maria Lucia Taylor
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

5.  Validation of western blot for Histoplasma capsulatum antibody detection assay.

Authors:  Marcos de Abreu Almeida; Cláudia Vera Pizzini; Lisandra Serra Damasceno; Mauro de Medeiros Muniz; Rodrigo Almeida-Paes; Regina Helena Saramago Peralta; José Mauro Peralta; Raquel de Vasconcelos Carvalhaes Oliveira; Alexandre Gomes Vizzoni; Carla Lourenço Tavares de Andrade; Rosely Maria Zancopé-Oliveira
Journal:  BMC Infect Dis       Date:  2016-02-24       Impact factor: 3.090

6.  Intramedullary histoplasmosis lesion in children: A case report.

Authors:  José Renan Miranda Cavalcante Filho; Patrícia Rodrigues Naufal Spir; Gustavo Maldonado Cortez; Adib Saraty Malveira; Felipe Franco Pinheiro Gaia
Journal:  Surg Neurol Int       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.